Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
2014 2
2015 2
2017 3
2018 6
2019 5
2020 6
2021 6
2022 8
2023 12
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for rano bm
Search for Cano BM instead (1 results)
Response assessment criteria for brain metastases: proposal from the RANO group.
Lin NU, Lee EQ, Aoyama H, Barani IJ, Barboriak DP, Baumert BG, Bendszus M, Brown PD, Camidge DR, Chang SM, Dancey J, de Vries EG, Gaspar LE, Harris GJ, Hodi FS, Kalkanis SN, Linskey ME, Macdonald DR, Margolin K, Mehta MP, Schiff D, Soffietti R, Suh JH, van den Bent MJ, Vogelbaum MA, Wen PY; Response Assessment in Neuro-Oncology (RANO) group. Lin NU, et al. Lancet Oncol. 2015 Jun;16(6):e270-8. doi: 10.1016/S1470-2045(15)70057-4. Epub 2015 May 27. Lancet Oncol. 2015. PMID: 26065612 Review.
The medical literature is difficult to interpret because of substantial variation in the response and progression criteria used across clinical trials. The Response Assessment in Neuro-Oncology Brain Metastases (RANO-BM) working group is an international, multidisci …
The medical literature is difficult to interpret because of substantial variation in the response and progression criteria used across clini …
Tepotinib Efficacy and Safety in Patients with MET Exon 14 Skipping NSCLC: Outcomes in Patient Subgroups from the VISION Study with Relevance for Clinical Practice.
Le X, Sakai H, Felip E, Veillon R, Garassino MC, Raskin J, Cortot AB, Viteri S, Mazieres J, Smit EF, Thomas M, Iams WT, Cho BC, Kim HR, Yang JC, Chen YM, Patel JD, Bestvina CM, Park K, Griesinger F, Johnson M, Gottfried M, Britschgi C, Heymach J, Sikoglu E, Berghoff K, Schumacher KM, Bruns R, Otto G, Paik PK. Le X, et al. Clin Cancer Res. 2022 Mar 15;28(6):1117-1126. doi: 10.1158/1078-0432.CCR-21-2733. Clin Cancer Res. 2022. PMID: 34789481 Free PMC article. Clinical Trial.
An ad hoc retrospective analysis using Response Assessment in Neuro-Oncology Brain Metastases (RANO-BM) criteria assessed intracranial activity. RESULTS: 152 patients were evaluable for efficacy (median age: 73.1). ...Treatment-naive (n = 69) versus previously treat …
An ad hoc retrospective analysis using Response Assessment in Neuro-Oncology Brain Metastases (RANO-BM) criteria assessed intr …
Effect of MRI-based semiautomatic size-assessment in cerebral metastases on the RANO-BM classification.
Bauknecht HC, Klingebiel R, Hein P, Wolf C, Bornemann L, Siebert E, Bohner G. Bauknecht HC, et al. Clin Neuroradiol. 2020 Jun;30(2):263-270. doi: 10.1007/s00062-019-00785-1. Epub 2019 Jun 13. Clin Neuroradiol. 2020. PMID: 31197388
MATERIAL AND METHODS: Brain metastases (n = 131) in 38 patients, assessed by contrast-enhanced MRI, were retrospectively evaluated at two timepoints (baseline, follow-up) by two experienced neuroradiologists in a blinded manner. The response assessment in neuro-oncology (RANO …
MATERIAL AND METHODS: Brain metastases (n = 131) in 38 patients, assessed by contrast-enhanced MRI, were retrospectively evaluated at two ti …
Response Assessment in Brain Metastases Managed by Stereotactic Radiosurgery: A Reappraisal of the RANO-BM Criteria.
Douri K, Iorio-Morin C, Mercure-Cyr R, Figueiredo G, Touchette CJ, Masson-Côté L, Mathieu D. Douri K, et al. Curr Oncol. 2023 Oct 24;30(11):9382-9391. doi: 10.3390/curroncol30110679. Curr Oncol. 2023. PMID: 37999099 Free PMC article.
A ROC curve was generated using varying diameter thresholds to assess the sensitivity and specificity of current RANO-BM criteria. RESULTS: 249 metastases in 67 patients were included in the analysis. ...CONCLUSIONS: Current RANO-BM criteria unreliably …
A ROC curve was generated using varying diameter thresholds to assess the sensitivity and specificity of current RANO-BM crite …
PET imaging in patients with brain metastasis-report of the RANO/PET group.
Galldiks N, Langen KJ, Albert NL, Chamberlain M, Soffietti R, Kim MM, Law I, Le Rhun E, Chang S, Schwarting J, Combs SE, Preusser M, Forsyth P, Pope W, Weller M, Tonn JC. Galldiks N, et al. Neuro Oncol. 2019 May 6;21(5):585-595. doi: 10.1093/neuonc/noz003. Neuro Oncol. 2019. PMID: 30615138 Free PMC article. Review.
Brain metastases (BM) from extracranial cancer are associated with significant morbidity and mortality. ...The use of systemic treatment for intracranial disease control also is improving. BM diagnosis, treatment planning, and follow-up is most often based on contra …
Brain metastases (BM) from extracranial cancer are associated with significant morbidity and mortality. ...The use of systemic treatm …
The Role of Molecular Imaging in Patients with Brain Metastases: A Literature Review.
Urso L, Bonatto E, Nieri A, Castello A, Maffione AM, Marzola MC, Cittanti C, Bartolomei M, Panareo S, Mansi L, Lopci E, Florimonte L, Castellani M. Urso L, et al. Cancers (Basel). 2023 Apr 6;15(7):2184. doi: 10.3390/cancers15072184. Cancers (Basel). 2023. PMID: 37046845 Free PMC article. Review.
Over the last several years, molecular imaging has gained a primary role in the evaluation of patients with brain metastases (BM). Therefore, the "Response Assessment in Neuro-Oncology" (RANO) group recommends amino acid radiotracers for the assessment of BM. …
Over the last several years, molecular imaging has gained a primary role in the evaluation of patients with brain metastases (BM). Th …
PACS-Integrated Tools for Peritumoral Edema Volumetrics Provide Additional Information to RANO-BM-Based Assessment of Lung Cancer Brain Metastases after Stereotactic Radiotherapy: A Pilot Study.
Kaur M, Cassinelli Petersen G, Jekel L, von Reppert M, Varghese S, Dixe de Oliveira Santo I, Avesta A, Aneja S, Omuro A, Chiang V, Aboian M. Kaur M, et al. Cancers (Basel). 2023 Sep 30;15(19):4822. doi: 10.3390/cancers15194822. Cancers (Basel). 2023. PMID: 37835516 Free PMC article.
In this study, we aimed to compare volumetric changes of edema to RANO-BM-based measurements of contrast-enhancing lesion size. Patients with NSCLC METS 10 mm on post-contrast T1-weighted image and treated with SRT had measurements for up to seven follow-up scans us …
In this study, we aimed to compare volumetric changes of edema to RANO-BM-based measurements of contrast-enhancing lesion size …
Comparing available criteria for measuring brain metastasis response to immunotherapy.
Qian JM, Mahajan A, Yu JB, Tsiouris AJ, Goldberg SB, Kluger HM, Chiang VLS. Qian JM, et al. J Neurooncol. 2017 May;132(3):479-485. doi: 10.1007/s11060-017-2398-8. Epub 2017 Mar 8. J Neurooncol. 2017. PMID: 28275886 Clinical Trial.
The response assessment in neuro-oncology (RANO) working group recently proposed standardized response criteria for brain metastases (RANO-BM). ...We here additionally assessed response using standard RECIST 1.1, RANO high-grade glioma (RANO-HGG …
The response assessment in neuro-oncology (RANO) working group recently proposed standardized response criteria for brain metastases …
Volumetric analysis: Rethinking brain metastases response assessment.
Ocaña-Tienda B, Pérez-Beteta J, Romero-Rosales JA, Asenjo B, Ortiz de Mendivil A, Pérez Romasanta LA, Albillo Labarra JD, Nagib F, Vidal Denis M, Luque B, Arana E, Pérez-García VM. Ocaña-Tienda B, et al. Neurooncol Adv. 2023 Dec 10;6(1):vdad161. doi: 10.1093/noajnl/vdad161. eCollection 2024 Jan-Dec. Neurooncol Adv. 2023. PMID: 38187872 Free PMC article.
BACKGROUND: The Response Assessment in Neuro-Oncology for Brain Metastases (RANO-BM) criteria are the gold standard for assessing brain metastases (BMs) treatment response. ...RESULTS: Our study showed that the proposed volumetric criteria outperformed the RANO …
BACKGROUND: The Response Assessment in Neuro-Oncology for Brain Metastases (RANO-BM) criteria are the gold standard for assess …
Society for Neuro-Oncology 2014 annual meeting updates on central nervous system metastases.
Lukas RV, Mehta MP, Lesniak MS. Lukas RV, et al. Neurooncol Pract. 2015 Jun;2(2):57-61. doi: 10.1093/nop/npv009. Epub 2015 Mar 24. Neurooncol Pract. 2015. PMID: 27621837 Free PMC article. Review.
RESPONSE ASSESSMENT: The Response Assessment for Neuro-Oncology criteria for brain metastases (RANO-BM) and the Neurological Assessment in Neuro-Oncology (NANO) criteria, which were both presented, are recapped. ...
RESPONSE ASSESSMENT: The Response Assessment for Neuro-Oncology criteria for brain metastases (RANO-BM) and the Neurological A …
45 results